Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Brouillet

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Current Opinion in Neurology|December 1, 1995
Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primatesE Brouillet, P Hantraye
Neuroreport|April 1, 1993
NMDA antagonists partially protect against MPTP induced neurotoxicity in miceE Brouillet, M F Beal
Nuclear Medicine and Biology|May 1, 1996
Synthesis and in vivo distribution of no-carrier-added N(omega)-Nitro-L-arginine [11C]methyl ester, a nitric oxide synthase inhibitorD Roeda, C Crouzel, E Brouillet, et al.
Progress in Neurobiology|October 9, 1999
Replicating Huntington's disease phenotype in experimental animalsE Brouillet, F Condé, M F Beal, et al.
Brain Research|March 30, 1999
Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthaseR J Ferrante, P Hantraye, E Brouillet, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboonL Schmid, M Bottlaender, E Brouillet, et al.
Experimental Neurology|October 30, 2001
Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acidN El Massioui, S Ouary, F Chéruel, et al.
Neuroscience Letters|August 15, 1994
Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10E Brouillet, D R Henshaw, J B Schulz, et al.
Experimental Neurology|June 1, 1993
Glutamate receptor binding sites in MPTP-treated miceU Wüllner, E Brouillet, O Isacson, et al.
Journal of Neurochemistry|October 1, 1995
Zolpidem displays heterogeneity in its binding to the nonhuman primate benzodiazepine receptor in vivoL Schmid, M Bottlaender, C Fuseau, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Opinion in Neurology|December 1, 1995
Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primatesE Brouillet, P Hantraye
Neuroreport|April 1, 1993
NMDA antagonists partially protect against MPTP induced neurotoxicity in miceE Brouillet, M F Beal
Nuclear Medicine and Biology|May 1, 1996
Synthesis and in vivo distribution of no-carrier-added N(omega)-Nitro-L-arginine [11C]methyl ester, a nitric oxide synthase inhibitorD Roeda, C Crouzel, E Brouillet, et al.
Progress in Neurobiology|October 9, 1999
Replicating Huntington's disease phenotype in experimental animalsE Brouillet, F Condé, M F Beal, et al.
Brain Research|March 30, 1999
Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthaseR J Ferrante, P Hantraye, E Brouillet, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboonL Schmid, M Bottlaender, E Brouillet, et al.
Experimental Neurology|October 30, 2001
Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acidN El Massioui, S Ouary, F Chéruel, et al.
Neuroscience Letters|August 15, 1994
Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10E Brouillet, D R Henshaw, J B Schulz, et al.
Experimental Neurology|June 1, 1993
Glutamate receptor binding sites in MPTP-treated miceU Wüllner, E Brouillet, O Isacson, et al.
Journal of Neurochemistry|October 1, 1995
Zolpidem displays heterogeneity in its binding to the nonhuman primate benzodiazepine receptor in vivoL Schmid, M Bottlaender, C Fuseau, et al.
Pageof 5